Vernalis to raise £68.5m 10/02/2012
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
AIM-traded insolvency specialist Begbies Traynor has warned of a slowdown in the second half of its year to April.
In a trading update ahead of full year results (set for release in July), Begbies said that overall, ‘work flow’ from its core business insolvency activities, representing more than 80 per cent of sales, grew significantly last year. However, Begbies noted that second half activity levels ‘were relatively flat’ compared with the first half, on account of a lesser number of UK corporate insolvencies.
Ric Traynor, the group's founder and executive chairman, highlighted recent government statistics showing a 5 per cent fall in insolvencies for the first quarter of 2010 compared with the previous quarter, noting that this decline was the ‘fifth successive fall in national insolvency volumes, reflecting the effects of government support measures and monetary policy’.
Such reduced volumes, cautioned Traynor, are likely to persist in the short-term, though the Begbies board insists corporate insolvency numbers will rise as the economic cycle develops, ‘consistent with historical patterns for insolvencies to lag the cycle.’
Furthermore, Begbies results are still expected to better last year's, when Begbies achieved 40 per cent growth in profits to £9.8 million on sales up 30 per cent to more than £62 million, although the financials will show a £800,000 one-off hit relating to Begbies' recent refinancing and the restructuring of its non-insolvency operations.
Following the trading update, Begbies shares shed 3.25p, more than 5 per cent, to 59.5p, down from their 115p 52-week high and valuing the business at £53.2 million.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
Drug discoverer Vernalis (VER) is to raise £68.5 million as part of a joint venture with US concern Tris Pharma.
Magnolia Petroleum (MAGP) has acquired 800 acres in the Mississippi Lime formation in Oklahoma.
Gold explorer Condor Resources (CNR) has reported encouraging results from drilling at its La India project in Nicaragua.
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.